Policy & Access Target opportunities with policy and advocacy teams by highlighting how accessible medicines and biosimilars reduce patient costs and improve adherence, aligning with AAM's mission to increase access and reduce shortages.

Industry Partnerships Engage manufacturers, distributors, and suppliers within the generic and biosimilar ecosystem to offer bundled solutions, co-marketing opportunities, or joint white papers that address shortages and supply chain resilience.

Evidence & Insights Leverage the organization’s white papers and savings reports as proof points in conversations with healthcare systems and payers about total cost of care, generic savings, and biosimilar adoption benefits.

Events & Thought Leadership Offer speaking slots, sponsorships, or executive roundtables at upcoming summits and Access 2025/GBMA-related events to position your products or services as solutions to shortages and access challenges.

Digital & Tech Enablement Propose digital tooling or services that support compliance, market access analytics, and patient access programs, leveraging their tech stack (LinkedIn Ads, iCIMS, web platforms) to reach decision makers efficiently.